Skip to content

The effect of acupuncture for patients with knee osteoarthritis: a protocol for a single-blinded, double-dummy randomised controlled trial

The effect of acupuncture for patients with knee osteoarthritis: a protocol for a single-blinded, double-dummy randomised controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100004526
Enrollment
Unknown
Registered
2021-03-06
Start date
2021-04-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

Sponsors

The First Affiliated Hospital of Henan University of CM
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 75 Years

Inclusion criteria

Inclusion criteria: Participants who meet all of the following requirements will be considered for inclusion: (1) Male or female, aged 45–75 years; (2) Diagnosis of knee osteoarthritis according to the American College of Rheumatology (ACR) criteria; (3) Radiologic confirmation of knee osteoarthritis[19] (Kellgren–Lawrence grade?to III); (4) The average daily pain over 40 points (on a 0-to 100-point scale); (5) Symptoms have been present for more than 6 months; (6) Signed informed consent.

Exclusion criteria

Exclusion criteria: Patients who meet any of the following criteria will be excluded from the trial: (1) are unable to walk; (2) have a serious infection of the knee; (3) have suspected tears in any ligaments or menisci or acute inflammation of the synovial capsule; (4) have a history of trauma, ligament damage, fracture, or surgery on the knee(s) within 6 months, causing pain or functional problems (history of knee replacement will be excluded); (5) have a history of local tumour/malignancy at the knee; (6) have physical or laboratory findings indicating infection, presence of autoimmune disease or inflammatory arthritis; (7) have knee pain caused by radiculopathy/herniation of an intervertebral disc; (8) have end-stage diseases or other suspected severe conditions such as deep vein thrombosis of the lower limb, oedema related to cancer or cancer treatment, severe blood coagulation disorders, uncontrolled systemic arterial hypertension and severe diabetes; (9) have a history of prolotherapy, hyaluronic acid injections or corticosteroids injections within 3 months; (10) have received acupuncture, electro-acupuncture, Tui-na therapy, massage, or physiotherapy 8 weeks prior to enrolment in the trial; (11) have severe pain in other regions; (12) have severe mental disorder(s); (13) are oversensitive to needles; and (14) are insensitive to pain due to advanced diabetes, neuropathy or use of strong painkillers.

Design outcomes

Primary

MeasureTime frame
Western Ontario and McMaster University Osteoarthritis Index scores;

Secondary

MeasureTime frame
Baker anxiety scale (BAI);Baker Depression scale (BDI);The pain visual analogue scale (VAS);Arthritis Quality of Life Measurement Scale Simplified Scale (AIMS2-SF);Expectancy Questionnaire;

Countries

China

Contacts

Public ContactYin Shuai

The First Affiliated Hospital of Henan University of Chinese Medicine

yinshuai880910@163.com+86 13458588608

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026